Updated Bayesian network meta-analysis on the efficacy and safety of PD−1 versus PD−L1 inhibitors in first−line treatment with chemotherapy for extensive−stage small-cell lung cancer

Updated Bayesian network meta-analysis on the efficacy and safety of PD−1 versus PD−L1 inhibitors in first−line treatment with chemotherapy for extensive−stage small-cell lung cancer

ObjectiveTo compare the efficacy and safety of programmed cell death 1 inhibitors plus chemotherapy (PD-1 + Chemo) and programmed cell death ligand 1 inhibitors plus chemotherapy (PD-L1 + Chemo) for the treatment of extensive-stage small-cell lung cancer (ES-SCLC).MethodsWe performed a meta-analysis...

Full description

Saved in:
Bibliographic Details
Main Authors: Ke Wang, Chuangjie Zheng, Xinrong Chen, Penghui Lin, Mengge Lin, Cuizhen Chen, Linzhu Zhai
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
extensive-stage small-cell lung cancer
efficacy and safety
PD-1 inhibitors
PD-L1 inhibitors
network meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1455306/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items